Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 20951-21000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT07207395
A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.
PHASE2Recruiting
30 participants
Started: Apr 29, 2025 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT06544330
A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease
PHASE1Recruiting
48 participants
Started: Apr 29, 2025 · Completed: Apr 30, 2041
3 conditions1 sponsor5 locations
NCT06931977
Natural Product System and Lifestyle Modification
NARecruiting
120 participants
Started: Apr 29, 2025 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06466161
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
NARecruiting
110 participants
Started: Apr 29, 2025 · Completed: Sep 1, 2027
3 conditions1 sponsor1 location
NCT06814275
Project neuroARTEMIS
NARecruiting
189 participants
Started: Apr 29, 2025 · Completed: Dec 31, 2028
3 conditions4 sponsors1 location
NCT06868186
A Multicenter Study of RUS NE
NARecruiting
204 participants
Started: Apr 29, 2025 · Completed: Apr 30, 2026
1 condition7 sponsors4 locations
NCT06394869
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
NARecruiting
1,000 participants
Started: Apr 29, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor10 locations
NCT07205341
Detecting Changes in Arterial Blood Volume and Cardiac Efficiency
N/ARecruiting
20 participants
Started: Apr 29, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06952634
An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage
PHASE1Recruiting
48 participants
Started: Apr 29, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT06342544
Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.
PHASE3Recruiting
128 participants
Started: Apr 29, 2025 · Completed: Jun 30, 2029
1 condition1 sponsor1 location
NCT06859866
Efficacy of Adjunctive At-Home Photodynamic Therapy (aPDT) in the Treatment of Peri-Implant Mucositis
NARecruiting
30 participants
Started: Apr 29, 2025 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT06935812
Comparison of the Effects of Bimanual, Finger and VR Exercises in PwMCI
NARecruiting
106 participants
Started: Apr 29, 2025 · Completed: Dec 24, 2025
1 condition1 sponsor1 location
NCT05555550
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
EARLY_PHASE1Recruiting
30 participants
Started: Apr 29, 2025 · Completed: Sep 30, 2027
5 conditions3 sponsors1 location
NCT06963281
Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
PHASE1Recruiting
285 participants
Started: Apr 29, 2025 · Completed: Mar 31, 2028
1 condition2 sponsors9 locations
NCT07066995
Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
PHASE1/PHASE2Recruiting
60 participants
Started: Apr 29, 2025 · Completed: Dec 28, 2028
4 conditions1 sponsor1 location
NCT06846320
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
PHASE2Recruiting
315 participants
Started: Apr 29, 2025 · Completed: Nov 30, 2026
1 condition1 sponsor47 locations
NCT06990529
Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
PHASE2Recruiting
12 participants
Started: Apr 29, 2025 · Completed: Apr 13, 2029
1 condition2 sponsors1 location
NCT06858540
Blended Unified Protocol in Chinese Adolescents With Non-Suicidal Self-Injury
NARecruiting
12 participants
Started: Apr 29, 2025 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT07137195
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)
NARecruiting
47 participants
Started: Apr 29, 2025 · Completed: Jul 31, 2031
1 condition1 sponsor1 location
NCT06781333
Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
PHASE2Recruiting
8 participants
Started: Apr 29, 2025 · Completed: Jun 15, 2026
2 conditions1 sponsor1 location
NCT06955936
Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction
NARecruiting
60 participants
Started: Apr 29, 2025 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT06960707
Two Versus One Week Breast Radiotherapy (RT)
PHASE3Recruiting
400 participants
Started: Apr 29, 2025 · Completed: Dec 31, 2040
1 condition1 sponsor3 locations
NCT06471465
Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases
PHASE3Recruiting
84 participants
Started: Apr 29, 2025 · Completed: Aug 31, 2030
2 conditions1 sponsor10 locations
NCT06586255
Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
PHASE1Recruiting
10 participants
Started: Apr 29, 2025 · Completed: Apr 30, 2027
2 conditions1 sponsor1 location
NCT06356220
GF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health)
NARecruiting
120 participants
Started: Apr 29, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06747468
Avexitide for Treatment of Post-Bariatric Hypoglycemia
PHASE3Recruiting
75 participants
Started: Apr 29, 2025 · Completed: Oct 31, 2026
1 condition1 sponsor21 locations
NCT06526299
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
PHASE2Recruiting
51 participants
Started: Apr 29, 2025 · Completed: Dec 31, 2027
3 conditions3 sponsors3 locations
NCT07053306
SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia
PHASE1Recruiting
29 participants
Started: Apr 29, 2025 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06913010
DV 100 as a Framework for the Hospital Incident Command System
N/ARecruiting
20 participants
Started: Apr 29, 2025 · Completed: Oct 31, 2026
4 conditions6 sponsors1 location
NCT06958159
Hybrid Endoscopic Stricturotomy Plus Balloon Dilation Versus Stricturotomy Alone for Short Crohn's Disease Strictures
NARecruiting
40 participants
Started: Apr 29, 2025 · Completed: May 15, 2027
1 condition1 sponsor1 location
NCT06488781
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
PHASE2Recruiting
787 participants
Started: Apr 29, 2025 · Completed: Dec 31, 2028
2 conditions5 sponsors1 location
NCT06847191
NE3107 in Adults With Neurological Symptoms of Long COVID
PHASE2Recruiting
208 participants
Started: Apr 29, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor13 locations
NCT06959680
The Effect of Kinesiotaping on Posture and Balance in Patients With Postural Thoracic Hyperkyphosis
NARecruiting
48 participants
Started: Apr 29, 2025 · Completed: Jan 29, 2026
5 conditions1 sponsor2 locations
NCT06527222
A Study of Ranolazine in ALS
PHASE2Recruiting
72 participants
Started: Apr 29, 2025 · Completed: May 31, 2026
1 condition2 sponsors7 locations
NCT07067255
Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer
PHASE1/PHASE2Recruiting
80 participants
Started: Apr 29, 2025 · Completed: Dec 28, 2029
4 conditions1 sponsor1 location
NCT06926621
A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I
PHASE2Enrolling by invitation
36 participants
Started: Apr 28, 2025 · Completed: Jul 24, 2028
1 condition1 sponsor6 locations
NCT06495450
Using Omnidirectional Virtual Reality and Treadmill Training for Chronic Stroke
NARecruiting
30 participants
Started: Apr 28, 2025 · Completed: Sep 6, 2026
1 condition2 sponsors1 location
NCT06915701
"Effect of Vitamin E (α-Tocopherol) on Clinical Activity and Inflammation in Rheumatoid Arthritis"
PHASE2/PHASE3Not yet recruiting
46 participants
Started: Apr 28, 2025 · Completed: Dec 15, 2027
1 condition2 sponsors1 location
NCT06908382
Neoadjuvant QL1706 Therapy for ESCC
PHASE2Recruiting
32 participants
Started: Apr 28, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06593652
Evaluating Caregiver Involvement in Primary Care-Based Brief Interventions for Adolescent Alcohol Use Problems
NARecruiting
585 participants
Started: Apr 28, 2025 · Completed: Sep 30, 2028
4 conditions2 sponsors1 location
NCT06928935
Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis
NANot yet recruiting
60 participants
Started: Apr 28, 2025 · Completed: Jan 1, 2028
1 condition1 sponsor1 location
NCT06895902
Suture Lid Spring for Lid Closure in Patients With Facial Nerve Palsy
EARLY_PHASE1Recruiting
10 participants
Started: Apr 28, 2025 · Completed: Jul 31, 2028
3 conditions1 sponsor2 locations
NCT06937294
Metformin in Post Chronic Pancreatitis Diabetes Mellitus
PHASE4Recruiting
58 participants
Started: Apr 28, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06944639
Comparative Study of Three Collagen Membranes: 1 Non-cross-linked and 2 Cross-linked
NAEnrolling by invitation
20 participants
Started: Apr 28, 2025 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT06883747
Clinical Trial of BMS-986504 in Recurrent GBM Patients
EARLY_PHASE1Recruiting
9 participants
Started: Apr 28, 2025 · Completed: Sep 28, 2027
1 condition1 sponsor1 location
NCT06699251
Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)
NARecruiting
500 participants
Started: Apr 28, 2025 · Completed: Feb 28, 2029
2 conditions4 sponsors2 locations
NCT06945523
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
PHASE1Recruiting
60 participants
Started: Apr 28, 2025 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT07007559
ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies
PHASE1/PHASE2Recruiting
80 participants
Started: Apr 28, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06746883
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
N/ARecruiting
100 participants
Started: Apr 28, 2025 · Completed: Jan 31, 2029
1 condition1 sponsor4 locations
NCT06956664
Exercise Therapy After Caudal Epidural Steroid Injection
NARecruiting
42 participants
Started: Apr 28, 2025 · Completed: Feb 15, 2026
3 conditions1 sponsor3 locations